Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.


Journal

Blood cancer discovery
ISSN: 2643-3249
Titre abrégé: Blood Cancer Discov
Pays: United States
ID NLM: 101764786

Informations de publication

Date de publication:
01 05 2023
Historique:
received: 08 08 2022
revised: 21 11 2022
accepted: 26 01 2023
medline: 2 5 2023
pubmed: 2 2 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

The rarity of malignant Hodgkin and Reed Sternberg (HRS) cells in classic Hodgkin lymphoma (cHL) limits the ability to study the genomics of cHL. To circumvent this, our group has previously optimized fluorescence-activated cell sorting to purify HRS cells. Using this approach, we now report the whole-genome sequencing landscape of HRS cells and reconstruct the chronology and likely etiology of pathogenic events leading to cHL. We identified alterations in driver genes not previously described in cHL, APOBEC mutational activity, and the presence of complex structural variants including chromothripsis. We found that high ploidy in cHL is often acquired through multiple, independent chromosomal gains events including whole-genome duplication. Evolutionary timing analyses revealed that structural variants enriched for RAG motifs, driver mutations in B2M, BCL7A, GNA13, and PTPN1, and the onset of AID-driven mutagenesis usually preceded large chromosomal gains. This study provides a temporal reconstruction of cHL pathogenesis. Previous studies in cHL were limited to coding sequences and therefore not able to comprehensively decipher the tumor complexity. Here, leveraging cHL whole-genome characterization, we identify driver events and reconstruct the tumor evolution, finding that structural variants, driver mutations, and AID mutagenesis precede chromosomal gains. This article is highlighted in the In This Issue feature, p. 171.

Identifiants

pubmed: 36723991
pii: 716329
doi: 10.1158/2643-3230.BCD-22-0128
pmc: PMC10150291
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

208-227

Subventions

Organisme : NCI NIH HHS
ID : K08 CA219473
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA240139
Pays : United States

Informations de copyright

©2023 American Association for Cancer Research.

Références

J Natl Cancer Inst. 1992 Dec 2;84(23):1789-93
pubmed: 1433367
Nat Genet. 2021 Oct;53(10):1434-1442
pubmed: 34594041
Nat Commun. 2019 Jul 5;10(1):2969
pubmed: 31278357
Nat Commun. 2021 Mar 25;12(1):1861
pubmed: 33767199
Blood. 2018 Oct 4;132(14):1526-1534
pubmed: 30049810
Leukemia. 2020 Jan;34(1):151-166
pubmed: 31431735
Nat Genet. 2014 Feb;46(2):116-25
pubmed: 24413735
Blood. 1995 Mar 1;85(5):1396-403
pubmed: 7858270
Nat Med. 2018 May;24(5):679-690
pubmed: 29713087
Nature. 2020 Feb;578(7793):122-128
pubmed: 32025013
Nature. 2013 Jul 11;499(7457):214-218
pubmed: 23770567
Leukemia. 2020 May;34(5):1476-1480
pubmed: 31836853
Nat Commun. 2020 Apr 21;11(1):1917
pubmed: 32317634
Haematologica. 2020 Feb 20;106(1):154-162
pubmed: 32079702
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1259-70
pubmed: 19336552
Genome Biol. 2011;12(4):R41
pubmed: 21527027
Semin Hematol. 2016 Jul;53(3):139-47
pubmed: 27496304
Blood. 2019 Sep 5;134(10):802-813
pubmed: 31292115
Nat Genet. 2018 Aug;50(8):1189-1195
pubmed: 30013179
Cancer Res. 2006 Nov 1;66(21):10332-8
pubmed: 17079453
Med. 2021 Oct 8;2(10):1171-1193.e11
pubmed: 35590205
Cancer Res. 2000 Feb 1;60(3):549-52
pubmed: 10676635
Nat Commun. 2020 Jul 17;11(1):3617
pubmed: 32680998
Nature. 2021 Jan;589(7841):299-305
pubmed: 33299181
Blood. 2018 May 31;131(22):2454-2465
pubmed: 29650799
Nat Commun. 2019 Aug 23;10(1):3835
pubmed: 31444325
Blood. 2010 Oct 28;116(17):3268-77
pubmed: 20628145
Commun Biol. 2021 Mar 29;4(1):424
pubmed: 33782531
Leukemia. 2021 Jul;35(7):2002-2016
pubmed: 33953289
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Med Oncol. 2012 Dec;29(5):3504-14
pubmed: 22492278
Nat Commun. 2018 Oct 1;9(1):4001
pubmed: 30275490
Cell. 2020 Oct 1;183(1):197-210.e32
pubmed: 33007263
Haematologica. 2018 Feb;103(2):278-287
pubmed: 29097495
Nat Genet. 2015 Dec;47(12):1402-7
pubmed: 26551669
Leukemia. 2020 Oct;34(10):2722-2735
pubmed: 32576963
Leuk Lymphoma. 2018 Jul;59(7):1574-1585
pubmed: 29473431
Nature. 2011 Mar 17;471(7338):377-81
pubmed: 21368758
J Natl Cancer Inst. 1990 May 16;82(10):855-8
pubmed: 2185367
Nature. 2009 Jun 4;459(7247):712-6
pubmed: 19412163
Blood. 1995 Aug 15;86(4):1464-8
pubmed: 7632954
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Am J Clin Exp Immunol. 2013 Feb 27;2(1):1-29
pubmed: 23885323
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12325-30
pubmed: 21746928
Nature. 2022 Aug;608(7924):724-732
pubmed: 35948631
Blood. 2018 May 31;131(22):2413-2425
pubmed: 29449275
Genes Chromosomes Cancer. 2016 Mar;55(3):251-67
pubmed: 26608593
EMBO J. 1993 Dec 15;12(13):4955-67
pubmed: 8262038
Nature. 2022 Apr;604(7906):517-524
pubmed: 35418684
Cell. 2021 Apr 15;184(8):2239-2254.e39
pubmed: 33831375
Blood. 1996 Apr 15;87(8):3124-34
pubmed: 8605326
PLoS One. 2021 May 4;16(5):e0248886
pubmed: 33945543
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10962-6
pubmed: 7971992
Nat Genet. 2015 Jun;47(6):672-6
pubmed: 25961940
PLoS One. 2020 Jan 3;15(1):e0227427
pubmed: 31899787
Blood. 2018 May 3;131(18):2036-2046
pubmed: 29467182
J Exp Med. 2012 Aug 27;209(9):1537-51
pubmed: 22891273
Am J Pathol. 2004 Mar;164(3):873-81
pubmed: 14982841
Blood. 2009 Nov 12;114(20):4503-6
pubmed: 19734449
Cell. 2019 May 2;177(4):821-836.e16
pubmed: 30982602
Blood. 2014 Oct 16;124(16):2544-53
pubmed: 25171927
Mutagenesis. 1988 Mar;3(2):83-7
pubmed: 3288842
Nat Genet. 2015 Sep;47(9):1067-72
pubmed: 26258849
Blood Adv. 2019 Dec 10;3(23):4065-4080
pubmed: 31816062
Nat Rev Cancer. 2016 May 25;16(6):387-98
pubmed: 27220482
Leukemia. 2021 Aug;35(8):2145-2150
pubmed: 34012133
J Vis Exp. 2017 Jun 10;(124):
pubmed: 28654052
Mutat Res. 1995 Mar;327(1-2):113-20
pubmed: 7532787
Blood. 2002 Feb 15;99(4):1381-7
pubmed: 11830490
Blood. 2015 Feb 12;125(7):1061-72
pubmed: 25488972
Nat Commun. 2020 Jul 7;11(1):3390
pubmed: 32636395
Nat Genet. 2019 Dec;51(12):1732-1740
pubmed: 31740835
J Exp Med. 1996 Oct 1;184(4):1495-505
pubmed: 8879220
Carcinogenesis. 1997 Nov;18(11):2191-6
pubmed: 9395220
Nat Commun. 2015 Dec 07;6:8866
pubmed: 26638776
Nat Commun. 2021 Aug 10;12(1):4803
pubmed: 34376657
Bioinformatics. 2021 Oct 11;37(19):3115-3119
pubmed: 33973999
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W262-7
pubmed: 20478831
Blood. 2020 Sep 17;136(12):1419-1432
pubmed: 32584970
Cancer Genet Cytogenet. 2008 Oct 15;186(2):110-4
pubmed: 18940474
J Exp Med. 2018 Mar 5;215(3):761-771
pubmed: 29374026
J Clin Oncol. 2016 Aug 10;34(23):2690-7
pubmed: 27069084
Blood Cancer Discov. 2020 Nov;1(3):258-273
pubmed: 33392515
J Clin Oncol. 2019 Jan 20;37(3):190-201
pubmed: 30523716
Ann N Y Acad Sci. 1995 Sep 29;764:523-4
pubmed: 7486580
Lancet Oncol. 2020 Nov;21(11):1433-1442
pubmed: 33035457
Genome Biol. 2016 Jun 16;17(1):128
pubmed: 27311963
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346

Auteurs

Francesco Maura (F)

Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Bachisio Ziccheddu (B)

Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Jenny Z Xiang (JZ)

Weill Cornell Medical College, New York, New York.
Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.

Bhavneet Bhinder (B)

Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.

Joel Rosiene (J)

Weill Cornell Medical College, New York, New York.

Federico Abascal (F)

The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, United Kingdom.

Kylee H Maclachlan (KH)

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Kenneth Wha Eng (KW)

Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.

Manik Uppal (M)

Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.

Feng He (F)

Weill Cornell Medical College, New York, New York.

Wei Zhang (W)

Weill Cornell Medical College, New York, New York.

Qi Gao (Q)

Memorial Sloan Kettering Cancer Center, New York, New York.

Venkata D Yellapantula (VD)

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Pathology and Laboratory Medicine at Children's Hospital Los Angeles, Los Angeles, California.

Vicenta Trujillo-Alonso (V)

Weill Cornell Medical College, New York, New York.

Sunita I Park (SI)

Department of Pathology, Children's Hospital of Atlanta, Atlanta, Georgia.

Matthew J Oberley (MJ)

Caris Life Sciences, Phoenix, Arizona.

Elizabeth Ruckdeschel (E)

Department of Pathology, Upstate Medical University, Syracuse, New York.

Megan S Lim (MS)

Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Philadelphia.

Gerald B Wertheim (GB)

Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, Philadelphia.

Matthew J Barth (MJ)

Department of Pediatrics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Terzah M Horton (TM)

Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Andriy Derkach (A)

Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Alexandra E Kovach (AE)

Children's Hospital of Los Angeles, Los Angeles, California.

Christopher J Forlenza (CJ)

Memorial Sloan Kettering Cancer Center, New York, New York.

Yanming Zhang (Y)

Memorial Sloan Kettering Cancer Center, New York, New York.

Ola Landgren (O)

Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Craig H Moskowitz (CH)

Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Ethel Cesarman (E)

Weill Cornell Medical College, New York, New York.

Marcin Imielinski (M)

Weill Cornell Medical College, New York, New York.
Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Olivier Elemento (O)

Weill Cornell Medical College, New York, New York.
Englander Institute for Precision Medicine, Institute for Computational Biomedicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, New York.

Mikhail Roshal (M)

Memorial Sloan Kettering Cancer Center, New York, New York.

Lisa Giulino-Roth (L)

Weill Cornell Medical College, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH